Drugs / Budesonide and Formoterol Fumarate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07352488 Background | Jan 2026 → Sep 2027 expected | allergic asthma | Henan University of Traditional Chinese Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Budesonide and Formoterol Fumarate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07352488 ↗ |
| Route | Inhaled | “Budesonide and Formoterol Fumarate Powder for Inhalation will be taken twice daily.” NCT07352488 ↗ |